Double Deferred Long Term Liab from 2010 to 2024
| 002901 Stock | 32.74 0.69 2.15% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 65.9 M | Current Value 69.2 M | Quarterly Volatility 28.1 M |
Check Double Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Double Medical's main balance sheet or income statement drivers, such as Interest Expense of 7.5 M, Other Operating Expenses of 17.8 M or Net Income Applicable To Common Shares of 443.1 M, as well as many indicators such as . Double financial statements analysis is a perfect complement when working with Double Medical Valuation or Volatility modules.
Double | Deferred Long Term Liab |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Double Stock
Double Medical financial ratios help investors to determine whether Double Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Double with respect to the benefits of owning Double Medical security.